Diacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in Cancer

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2016 Nov 2

PMID 27800476

Citations 30

Authors

Matthew J Riese

Edmund K Moon

Bryon D Johnson

Steven M Albelda

Affiliations

Soon will be listed here.

Abstract

Diacylglycerol kinases (DGKs) are a family of enzymes that catalyze the metabolism of diacylglycerol (DAG). Two isoforms of DGK, DGKα, and DGKζ, specifically regulate the pool of DAG that is generated as a second messenger after stimulation of the T cell receptor (TCR). Deletion of either isoform in mouse models results in T cells bearing a hyperresponsive phenotype and enhanced T cell activity against malignancy. Whereas, DGKζ appears to be the dominant isoform in T cells, rationale exists for targeting both isoforms individually or coordinately. Additional work is needed to rigorously identify the molecular changes that result from deletion of DGKs in order to understand how DAG contributes to T cell activation, the effect of DGK inhibition in human T cells, and to rationally develop combined immunotherapeutic strategies that target DGKs.

Citing Articles

A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8 T cell fitness in solid tumours.

Pretto S, Yu Q, Bourdely P, Trusso Cafarello S, Van Acker H, Verelst J Nat Metab. 2025; .

PMID: 40065102 DOI: 10.1038/s42255-025-01233-w.

Unveiling the Innate and Adaptive Immunity Interplay: Global Transcriptomic Profiling of the Host Immune Response in Endophthalmitis in a Murine Model.

Khapuinamai A, Rudraprasad D, Pandey S, Mishra D, Joseph J ACS Omega. 2024; 9(40):41491-41503.

PMID: 39398165 PMC: 11466307. DOI: 10.1021/acsomega.4c05081.

Exploring the multifaceted role of RASGRP1 in disease: immune, neural, metabolic, and oncogenic perspectives.

Fan S, Kang B, Li S, Li W, Chen C, Chen J Cell Cycle. 2024; 23(6):722-746.

PMID: 38865342 PMC: 11229727. DOI: 10.1080/15384101.2024.2366009.

Global Transcriptomic Profiling of Innate and Adaptive Immunity During Aspergillus flavus Endophthalmitis in a Murine Model.

Khapuinamai A, Rudraprasad D, Pandey S, Gandhi J, Mishra D, Joseph J Invest Ophthalmol Vis Sci. 2024; 65(4):44.

PMID: 38687493 PMC: 11067548. DOI: 10.1167/iovs.65.4.44.

Therapeutic Potential of CRISPR/Cas in Hashimoto's Thyroiditis: A Comprehensive Review.

Upreti A, Mukherjee S Curr Gene Ther. 2024; 24(3):179-192.

PMID: 38310457 DOI: 10.2174/0115665232266508231210154930.

References

Baldanzi G, Pighini A, Bettio V, Rainero E, Traini S, Chianale F . SAP-mediated inhibition of diacylglycerol kinase α regulates TCR-induced diacylglycerol signaling. J Immunol. 2011; 187(11):5941-51. PMC: 3221890. DOI: 10.4049/jimmunol.1002476. View

Guo R, Wan C, Carpenter J, Mousallem T, Boustany R, Kuan C . Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta. Proc Natl Acad Sci U S A. 2008; 105(33):11909-14. PMC: 2575297. DOI: 10.1073/pnas.0711856105. View

Hannier S, Tournier M, Bismuth G, Triebel F . CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. J Immunol. 1998; 161(8):4058-65. View

Joshi R, Schmidt A, Das J, Pytel D, Riese M, Lester M . The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling. Sci Signal. 2013; 6(303):ra102. PMC: 4096120. DOI: 10.1126/scisignal.2004373. View

Yang J, Zhang P, Krishna S, Wang J, Lin X, Huang H . Unexpected positive control of NFκB and miR-155 by DGKα and ζ ensures effector and memory CD8+ T cell differentiation. Oncotarget. 2016; 7(23):33744-64. PMC: 5085116. DOI: 10.18632/oncotarget.8164. View

Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M . Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis. Sci Signal. 2013; 6(268):ra21. PMC: 3737252. DOI: 10.1126/scisignal.2003848. View

Jennings W, Doshi S, DSouza K, Epand R . Molecular properties of diacylglycerol kinase-epsilon in relation to function. Chem Phys Lipids. 2015; 192:100-108. DOI: 10.1016/j.chemphyslip.2015.06.003. View

Freeman G, Sharpe A . A new therapeutic strategy for malaria: targeting T cell exhaustion. Nat Immunol. 2012; 13(2):113-5. PMC: 3690321. DOI: 10.1038/ni.2211. View

Shin D, Ribas A . The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?. Curr Opin Immunol. 2015; 33:23-35. DOI: 10.1016/j.coi.2015.01.006. View

10.

Gorentla B, Krishna S, Shin J, Inoue M, Shinohara M, Grayson J . Mnk1 and 2 are dispensable for T cell development and activation but important for the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 2012; 190(3):1026-37. PMC: 3552100. DOI: 10.4049/jimmunol.1200026. View

11.

Callahan M, Postow M, Wolchok J . Targeting T Cell Co-receptors for Cancer Therapy. Immunity. 2016; 44(5):1069-78. DOI: 10.1016/j.immuni.2016.04.023. View

12.

Wehbi V, Tasken K . Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units. Front Immunol. 2016; 7:222. PMC: 4896925. DOI: 10.3389/fimmu.2016.00222. View

13.

Zhong X, Hainey E, Olenchock B, Jordan M, Maltzman J, Nichols K . Enhanced T cell responses due to diacylglycerol kinase zeta deficiency. Nat Immunol. 2003; 4(9):882-90. DOI: 10.1038/ni958. View

14.

Zhong X, Hainey E, Olenchock B, Zhao H, Topham M, Koretzky G . Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase zeta. J Biol Chem. 2002; 277(34):31089-98. DOI: 10.1074/jbc.M203818200. View

15.

Perez de Castro I, Bivona T, Philips M, Pellicer A . Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus. Mol Cell Biol. 2004; 24(8):3485-96. PMC: 381594. DOI: 10.1128/MCB.24.8.3485-3496.2004. View

16.

Zha Y, Marks R, Ho A, Peterson A, Janardhan S, Brown I . T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha. Nat Immunol. 2006; 7(11):1166-73. DOI: 10.1038/ni1394. View

17.

Joshi R, Koretzky G . Diacylglycerol kinases: regulated controllers of T cell activation, function, and development. Int J Mol Sci. 2013; 14(4):6649-73. PMC: 3645659. DOI: 10.3390/ijms14046649. View

18.

Santos T, Carrasco S, Jones D, Merida I, Eguinoa A . Dynamics of diacylglycerol kinase zeta translocation in living T-cells. Study of the structural domain requirements for translocation and activity. J Biol Chem. 2002; 277(33):30300-9. DOI: 10.1074/jbc.M200999200. View

19.

Quann E, Liu X, Altan-Bonnet G, Huse M . A cascade of protein kinase C isozymes promotes cytoskeletal polarization in T cells. Nat Immunol. 2011; 12(7):647-54. PMC: 3119370. DOI: 10.1038/ni.2033. View

20.

Riese M, Grewal J, Das J, Zou T, Patil V, Chakraborty A . Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses. J Biol Chem. 2010; 286(7):5254-65. PMC: 3037638. DOI: 10.1074/jbc.M110.171884. View